Aurinia Pharmaceuticals Inc (AUP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 83,220 | 77,705 | 77,114 | 73,468 | 70,008 |
| Cost of Goods | 6,555 | 6,505 | 8,799 | 8,177 | 7,115 |
| Gross Profit | 76,665 | 71,200 | 68,315 | 65,291 | 62,893 |
| Operating Expenses | 30,324 | 29,778 | 35,076 | 35,546 | 42,696 |
| Operating Income | 46,341 | 41,422 | 33,239 | 29,745 | 20,197 |
| Interest Expense | 948 | 1,012 | 1,047 | 1,099 | 1,117 |
| Other Income | 3,393 | 3,515 | 3,498 | 3,316 | 3,076 |
| Pre-tax Income | 48,786 | 43,925 | 35,690 | 31,962 | 22,156 |
| Income Tax | 11,372 | 9,570 | -175,104 | 411 | 643 |
| Net Income Continuous | 37,414 | 34,355 | 210,794 | 31,551 | 21,513 |
| Net Income | $37,414 | $34,355 | $210,794 | $31,551 | $21,513 |
| EBITDA(a) | $54,568 | $49,753 | $41,601 | $37,926 | $28,137 |